Diagnostic Ventures

Diagnostic Ventures specializes in rapid sepsis detection through a patented process that identifies sepsis-causing pathogens from whole blood in just 20 minutes. The company collaborates with leading researchers and has developed its technology since 2016, with initial funding from a $5.2 million grant from the National Institute of Health. Their... services include pathological testing, advanced microscopy, and chemical research, aimed at improving patient care in time-critical conditions. Although their product is still under development and not yet FDA approved, they are committed to transparency and meeting the unique needs of healthcare providers.Read More